While MNA-NBs are generally resistant to retinoic acid (RA) treatment, the specific inhibition of MYCN expression by BGA002 has been shown to restore the RA response in MNA-NB, leading to a significant increase in survival in an MNA-NB mouse model [123]. The gene discussed is MYCN; the disease is neuroblastoma.